Thursday Preview: Can Torrent Pharmaceuticals Rebound After Recent Decline?

Torrent Pharmaceuticals Ltd., a key player in the Indian pharma sector, has faced recent bearish signals, with its stock dropping by 2.71% on February 11, 2025. Despite this, the company has shown resilience, rising for three consecutive sessions earlier this month and delivering a 252% return over the last five years. Analysts remain optimistic, with a target price of ₹3,522.40, suggesting a potential upside of 15.11%. Investors are closely watching whether Torrent can sustain its growth momentum.
Sources: INDmoney, Trendlyne, Economic Times, Screener